Previously we demonstrated that muscadine grape skin extract (MSKE), a natural product, significantly inhibited androgen-responsive prostate cancer cell growth by inducing apoptosis through the targeting of survival pathways. However, the therapeutic effect of MSKE on more aggressive androgen-independent prostate cancer remains unknown. This study examined the effects of MSKE treatment in metastatic prostate cancer using complementary PC-3 cells and xenograft model. MSKE significantly inhibited PC-3 human prostate cancer cell tumor growth in vitro and in vivo. The growth-inhibitory effect of MSKE appeared to be through the induction of cell-cycle arrest. This induction was accompanied by a reduction in the protein expression of Hsp40 and cell-cycle regulation proteins, cyclin D1 and NF-kBp65. In addition, MSKE induced p21 expression independent of wild-type p53 induced protein expression. Moreover, we demonstrate that MSKE significantly inhibited cell migration in PC-3 prostate cancer cells. Overall, these results demonstrate that MSKE inhibits prostate tumor growth and migration, and induces cell-cycle arrest by targeting Hsp40 and proteins involved in cell-cycle regulation and proliferation. This suggests that MSKE may also be explored either as a neo-adjuvant or therapeutic for castration resistant prostate cancer.
Introduction
Epidemiological studies have demonstrated a link between prostate cancer incidence and diet [1, 2, 3] . Clinical trials with patients consuming dietary phenolic phytochemicals have demonstrated that these agents have potential chemopreventative properties with low toxicity [4] . In a previous study, patients treated with green tea catechins showed a 90% reduction in high-grade prostate intra-epithelial neoplasia incidence [5] . Dietary agents, such as pomegranate and green tea, are rich in polyphenols and have been shown to be effective against cancer [6] . Polyphenols are known to have anti-proliferative and antioxidant effects on prostate cancer cells [3, 7] .
MSKE contains components that are like those found in green tea and pomegranate, including polyphenol constituents such as gallic acid, ellagic acid glucosides, catechin, quercetin, kaempferol, and several anthocyanins [8] . We have demonstrated that MSKE, like other plant polyphenols, also has antiproliferative and antiapoptotic properties. For example, our previous study showed that MSKE inhibited growth, induced apoptosis, and decreased the expression of AKT through AKT degradation in a series of transformed prostate epithelial cell lines [9] . AKT is a client protein of heat shock proteins (Hsp) involved in signal transduction of prostate cancer cell growth. Degradation of client proteins, cell-cycle arrest, and induction of apoptosis are characteristic of Hsp40 inhibition [10] . The effectiveness of MSKE, therefore, can potentially be due to inhibition of Hsp40, leading to degradation and/ or inactivity of oncogenic client proteins.
Heat shock proteins are potential targets for prevention and treatment of prostate cancer since they have been linked to poor clinical outcomes in prostate cancer and mediate important biological activities [10] . Heat shock proteins which are classified as small and large proteins are grouped by their molecular weight [11] . Hsp90, Hsp70, and Hsp40 assemble into complexes with co-chaperones and other proteins to mediate the folding of client proteins into their stable tertiary structure which can lead to degradation of client proteins [12] . Hsp40 and Hsp70 form a complex in which Hsp40 functions as a co-chaperone. In this complex, Hsp40 regulates Hsp70 by inducing its ATPase activity, resulting in stabilization of the Hsp70-peptide complex [13] . Together, Hsp40 and Hsp70 are involved in protein folding and prevent formation of cellular aggregates [14] . A subclass of Hsp40 can function independently of Hsp70 to prevent protein aggregation [11] . Studies have shown that upregulation of the different subclass of Hsp40 has been associated with high-grade intraepithelial neoplasia and maintaining stability of client proteins [15, 16] .
In this study, we show that MSKE significantly inhibits the growth and migration of metastatic prostate cancer cells, primarily through induction of cell-cycle arrest by targeting Hsp40. These data, therefore, suggest that MSKE has therapeutic potential to inhibit the growth of advanced forms of prostate cancer, and that MSKE warrants further investigation as a treatment for castrate resistant prostate cancer.
Materials and methods

Chemicals and preparation
Ethanol and Propidium iodide (PI) were purchased from Sigma-Aldrich Chemical Co. (Milwaukee, WI). Preparation of MSKE from the Ison cultivar has been previously described [9] .
Reagents
Antibodies used in this study were as follows: Hsp27, Hsp40, Hsp70, Hsp90, NF8-B/p65, and Cyclin D1 (Cell Signaling), and VEGF (Santa Cruz), and actin (Chemicon). Plasmids used in this study were HSP40 CRISP/Cas9 KO (Santa Cruz), and Control CRISP/Cas9 (Santa Cruz). Resveratrol was purchased from the Sigma Chemical Company (St. Louis, MO). Gaithersburg, MD). The membrane was blocked using WesternBreeze Chemiluminescent Immunodetection Kit (Invitrogen) and probed with anti-Hsp27, Hsp40, Hsp60, Hsp70, Hsp90, NF-kB p65, VEGF, p53 (Ser15), p21 and cyclin D1
(1:500 diluted in manufacturer primary antibody diluent buffer) overnight at 4 C.
After washing with Invitrogen buffer wash (Invitrogen), the blots were treated with either Invitrogen Alk-Phos conjugated (anti-Mouse) or (anti-rabbit) for 30 minutes and washed several times. Proteins were detected by the enhanced chemiluminescence system (Invitrogen). Western analysis was performed on total cell lysate.
Confocal microscopy
The 
Wound healing assay
PC-3 cells were seeded on 60 mm culture dishes at 90% confluence in growth medium overnight. Several wounds were created using 10-ul micro-pipette tip in 100% confluent cells. The wounded monolayer was then washed twice with PBS to remove cell debris. After culturing to various time points (12, 24, 48 , and 72 hours) we supplemented with serum free medium with or without 20 or 40 mg/ml of MSKE. After each time point, migrated cells were analyzed by microscopy.
Invasion assay
Invasiveness into the basement membrane was assayed using the CytoSelect were added to the upper compartment of transwell cell culture chamber. A total of 10% FBS in 500 ml of media was used as a chemo-attractant in the lower chamber.
After 48 hours of incubation at 37 in 5% CO 2 atmosphere, cells remaining on the lower surface of the membrane were carefully removed and transferred to a clean well containing 400 ml of the Cell stain solution. They were incubated at 25 C for 10 minutes, fixed and counted according to the manufacturer's instructions and photographed using the Opelco Olympus 1 Â 71 Ò inverted microscope (Optical Elements Cooperation) and DP70 BSW software for Olympus.
In vivo xenograft bioassay
Male athymic nude mice (BALB/c nu/nu, 20e22 g), 5e6 weeks old, were obtained from Charles River (Frederick, MD). Animals were housed in filter-top cages at Howard University Veterinary Animal Facility and consumed powdered AIN-93M diet (New Brunswick, NJ) prepared weekly and fresh tap water ad libitum. All experimental protocols were in accordance with the National Institutes of Health guidelines and were approved by the Animal Care and Use Committee of Howard University. Food consumption and body weights were recorded bi-weekly. After an acclimation period of 2 weeks, during which mice were fed control AIN-93M diet, the mice were randomly grouped into 5 experimental groups, with 10 animals in the control group and 10 animals in each of the four MSKE treatment groups (50 mg/kg, 100 mg/kg, 200 mg/kg, 400 mg/kg) were administered by gavage twice a week. However, there was a total of seven animals in the highest treatment group (600 mg/kg) because three animals died prior to treatment. Two weeks later, PC-3 human prostate cancer cell xenografts were established in the mice by subcutaneous injection in the flank with PC-3 cells (1 Â 10 6 cells) in 50 ml of phosphate-buffered saline (PBS) plus 50 ml basement membrane extract (BME) (Trevigen, Gaithersburg, MD). and 48 hr. Trypan blue exclusion assay used for cell proliferation, western analysis described above was used for detection of proteins, and CytoSelect Ô 24-Well Cell Invasion Assay kit used for migration assay.
Transient transfection assay
Apoptosis phosphorylated signal transduction protein array
The human apoptosis protein array kit was used according to manufacturer's protocol (R&D systems). PC-3 metastatic prostate cells were plated at a density of 6 Â 10 5 cells in a 10-cm dish in complete RPMI medium and then treated with ethanol (control), 5, 10, 20 mg/ml MSKE for 24 h. The cells were rinsed with cold PBS and lysed according to manufacturer's protocol. The lysate (250 ug) was added to the nitrocellulose membrane array, which was incubated with the detection antibody cocktail.
After washing, secondary antibody (streptavidin-horseradish peroxidase, 1:2000) was added. Protein signals were detected by the enhanced chemiluminescence system. Western analysis was done on total cell lysates. Duplicate signals on the array were quantitated using Alpha Fluorochem imaging software (IMGEN Technologies).
Immunohistochemical staining
In brief, slides were incubated 1 hour in a 60 oven and rehydrated using a gradient of xylene and ethanol. Antigen Retrieval was performed with 10 mM Citrate Buffer.
The slides were blocked for 20 minutes, then incubated overnight at 4 C with primary antibody. Detection was performed as previously described [17, 18, 19] . For statistical analyses, an average of three fields of view per sample was used for counting and the average percent positive cells were counted and graphed. Statistical analyses were performed using the Student's t-test with p 0.05 establishing significance. The following antibody was used: Hsp40 (Cell Signaling cat. 4871).
Statistical analysis
All statistical procedures were carried out using GraphPad Prism Inc. version 5.0 software package (GraphPad Software, San Diego, CA). Statistical analysis evaluating apoptosis, cell viability, tumor burden, food consumption, and cell migration used ANOVA followed by student-Newman-Keuls post hoc test. 3. Results
MSKE inhibits PC-3 prostate cancer cell growth in vitro
As depicted in Fig. 1A and B, MSKE significantly inhibited PC-3 metastatic prostate cell growth by 50% after 72 hours and was sustained over time. The significant inhibition was not dose dependent. This was confirmed in our Clonogenic assay, as shown in Fig. 1B . We also demonstrated significant growth inhibition in other prostate cancer cells.
MSKE induces cell-cycle arrest and not apoptosis in PC-3 prostate cancer cells
The cell cycle analysis demonstrated that MSKE significantly (p 0.05) arrested cells during the G1 to S phase transition at 20 and 40 mg/ml MSKE compared to by adding 400 ml of ethanol and incubated on ice for 15 minutes. The cells were then centrifuged at 1500 rpm for 5 minutes and the pellet was re-suspended in 200 ml propidium iodide (PI) solution containing 50 mg/ml PI (Biotium), 0.1 mg/ml RNase A (Sigma-Aldrich), and 0.05% Triton X-100 (Sigma-Aldrich). The cellometer allows simultaneous acquisition of bright-field and fluorescence images for concentration, size, and viability measurement to measure cell cycle transition. The fluorescence intensity and size measurement were recorded for each cell contained within a data set, which was exported from the software into an Excel file, and imported into FlowJo (Tree Star, Oregon) for cytometric data analysis. Columns mean percentage of populated cells in G0/G1 phase of the cell cycle; bars, AESE. * for three independent experiments, is the significant difference between treated and control.
control after 12 ( Fig. 2A) and 24 hours (Fig. 2B) . Resveratrol, which was used as a control, has previously been shown to arrest prostate cancer cells, and confirmed the inhibitory effect of MSKE [9] . However, the PI analysis demonstrated that MSKE did not significantly induce apoptosis. This was confirmed by our Annexin-V FITC analysis (Fig. 1C) .
MSKE inhibits HSP40, NF-8B, cyclin D1 protein expression and induces wild-type p53 protein and p21 mRNA
We demonstrated in Fig. 3A and S1A and B Figure that MSKE decreased the expression of Hsp40, NF-8B, and Cyclin D1 which play a key role in cell survival [10, 14] .
However, the expression of other Hsps were not affected after 24 hours when compared to control. We also showed that MSKE reduced Hsp40 and other Hsp expression in other prostate cancer cells (Fig. 7B and S4A and S4B Figure) .
Confocal imaging confirmed that MSKE inhibited protein expression of Hsp40 (Fig. 3B ). In addition, we showed that MSKE induced p53 (Fig. 3C , and S1C Figure) , a marker involved in cell growth and mediation of p21 [20] . However, in our model p21 induction by MSKE in the LNCaP cells was independent of the increase in PC-3 cells (possess mutated p53) (Fig. 3D) The p21 increased was confirmed in our protein phosphorylated array (Fig. 7C ) and western blot analysis ( Fig. 3E and S1C Figure) . Overall, our results confirm the inhibitory effect of MSKE in PC-3 cells through pronounced cell-cycle arrest in G1-S phase transition.
MSKE inhibits prostate cancer cell migration and invasion
Cancer cells usually exhibit enhanced cellular motility to facilitate metastasis [21] .
We demonstrated that under control conditions, and with maintenance of the monolayer wound area for 24, 48, and 72 hours a concentration-dependent recovery of the area occurred after 72 hours (Fig. 4A) . However, when the wounded cell area was treated with MSKE at 20 and 40 mg/ml for 24, 48, and 72 hours there was a significant decrease in prostate cancer cell recovery. The migration assay as shown in Fig. 4B further confirmed that MSKE at 20 and 40 mg/ml inhibited migration activity of PC-3 cells after 48 hours. Treatment with 20 and 40 mg/ml MSKE prevented respectively w82% and 91% of cells from migrating. Importantly, we showed that knocking out Hsp40 (Fig. 5A and S2A Figure) using CRISP/Cas9 system influenced other cell cycle proteins, specifically, NF-kBp65 (S2B Figure) and decreased metastatic prostate cancer cell growth (Fig. 5B) and migration (Fig. 5C ).
MSKE treatment inhibits tumor burden
Because of the inhibitory effects demonstrated in vitro, we conducted preclinical studies to evaluate the growth inhibitory effects of MSKE in a PC-3 xenograft mouse model. The results showed that dietary administration of MSKE at the various concentrations did not significantly affect the body weights (Fig. 6A) or food consumption (Fig. 6B ) of the treated mice compared to the control. There was significant difference (p < 0.05) between the tumor burden of the treated groups and the control at weeks 5 and 6 after injection of PC-3 tumor cells (Fig. 6C ) at 5, 10, 100, 200, and 400 mg/kg MSKE consumption, lower tumor volume was observed (p < 0.5) compared to control mice. The reduction in the tumor burden between the 600 mg/kg group and the control group was marginally significant, which was probably due to small numbers in this treatment group because of death prior to treatment and Proteins (50 mg) were separated using 10% or 16% pre-cast Tris-Glycine gels and dry-transferred for seven minutes using iBlot machine (Invitrogen, Gaithersburg, MD) onto PVDF membranes (Invitrogen, the large variation in tumor size observed in the control group. However, the decrease in tumor burden was not dose-dependent.
MSKE inhibits HSP40, HSP60, and NF-8B protein expression in vivo
The expression of proliferation markers in xenograft tumors was analyzed by IHC and western analysis. As shown in Fig. 6D and S3A Figure, western blot analysis from the tumors showed a decreased in protein expression of Hsp40 marker in 50, 100, 200, 400, and 600 mg/kg MSKE treatment groups compared to the control group. This reduction in Hsp40 protein expression was confirmed at the highest dose level (600 mg/kg) of MSKE treatment in vivo (Fig. 7D) . There was also a decrease in the expression of NF-8Bp65 expression in 600 mg/kg groups ( and S3B Figure) . This decrease in protein expression was consistent with that observed in vitro. However, we did not see a decrease in Hsp70, PCNA, and VEGF ( Fig. 6D and S3A and S3B Figure) .
Discussion
This study examined whether MSKE is an effective inhibitor of metastatic prostate cancer, in vitro and in vivo. This study demonstrated that MSKE significantly inhibited cell growth in a non-dose-dependent manner in PC-3 metastatic prostate cancer cells in vitro. This was accompanied by induction of cell cycle arrest.
Other studies that have demonstrated significant growth-inhibitory effects by naturally-occurring compounds on advanced prostate cancer cell lines. For example, Gupta et al. (2000) showed that EGCG induced G 1 phase arrest in human prostate carcinoma cells [22] . Comparable results were also observed after treatment with resveratrol in PC-3 prostate cancer cells and quercetin in human osteosarcoma cells [23, 24] .
The reduction in cell growth and induction of cell cycle arrest by MSKE was accompanied by a decreased in Hsp40, and cyclin D1 protein expression. The decrease expression of Hsp40 and cyclin D1 was confirmed in our in vivo studies. In addition, we demonstrated that MSKE induces expression of cyclin-dependent kinase inhibitor p21 which is known regulator of cyclin D1 [25, 26] , a regulator of cells transitioning through G 1 and S phase of the cell cycle [27] . The induction of p21 in LNCaP cells was independent of p53 considering we showed an induction of p21 in PC-3 cells which possess a mutated p53. However, it has been shown that Hsp40 has a special relationship with p53 in protecting the cells, but known to lose its protection in the presence of a mutated p53 [28, 29, 30, 31, 32, 33, 34, 35, 36, 37] . Importantly, Akalin et al. (2001) demonstrated that Hsp40 plays a role in prostate cancer progression [38] .
These data, along with the current study, provide evidence of a connection between Hsp40 and other signaling molecules involved in cell cycle progression. The decrease in cyclin D1 described above was also accompanied by a decrease in NF-kB protein expression, whose transcriptional activity leads to the activation of cyclin D1 and is also involved in migration and prostate cancer progression [26, 39, 40] . We confirmed the reduction of NF-kB expression by MSKE in vivo.
Accordingly, we investigated the role of MSKE on cell migration and invasion, which are important hallmarks of cancer progression.
The invasive behavior of prostate cancer cells is associated with their ability to migrate and invade the surrounding tissue [41] . This study provides evidence that MSKE exerts an inhibitory effect on the motility and invasiveness of PC-3 prostate cancer metastatic cells. As shown in the results, the adhesion of PC-3 cells was markedly suppressed and invasion significantly inhibited by MSKE treatment and Hsp40 knockout. Previous studies have also shown that other natural polyphenols present in grapes, green tea, and tumeric can suppress invasion [42, 43] . Overall, our results indicate that MSKE inhibits metastatic prostate cancer cell growth by inhibiting cell migration and invasion and retarding cells transitioning from the G1 to S phase of the cell cycle through the targeting Hsp40 which is involved in cell growth, cell arrest, and cell invasion.
Importantly, we demonstrated in vivo MSKE ability to significantly reduced tumor burden as early as four weeks after initial subcutaneous injection of cells, while not significantly affecting body weight or food consumption. This anti-tumor effect is similar to previous in vivo studies that examined the effect of purified muscadine grape polyphenols on PC-3 prostate tumor cell growth [44, 45] .
In summary, MSKE treatment significantly inhibited the growth of metastatic prostate tumor cells in vitro and in vivo by inducing cell-cycle arrest through the targeting of Hsp40 which is involved in cell-cycle progression and cell migration. Furthermore, we demonstrated that MSKE was safe at high concentrations and had a beneficial effect on metastatic prostate cancer. The safety of MSKE was confirmed by a Phase I clinical trial of a related noble cultivar of muscadine grapes where safety of MPX (muscadine grape skin powder) on PSA doubling time in men with biochemical recurrence was studied [46] . Based on the present comprehensive findings, MSKE could be developed as a potential anticancer agent against castrate resistant prostate cancer.
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